Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chloe Mighton

Showing results (21-30 of 68) with videos related to

Pageof 7
Sort By:
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 3, 2019
Correction: Variant classification changes over time in BRCA1 and BRCA2Chloe Mighton, George S Charames, Marina Wang, et al.
HGG Advances|May 1, 2025
Pathogenic germline variants in small cell lung cancer: A systematic review and meta-analysisSami Ul Haq, Aleem Aamir, Chloe Mighton, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 12, 2019
Variant classification changes over time in BRCA1 and BRCA2Chloe Mighton, George S Charames, Marina Wang, et al.
CMAJ Open|November 25, 2020
Use of real-world evidence in cancer drug funding decisions in Canada: a qualitative study of stakeholders' perspectivesMarc Clausen, Chloe Mighton, Ruhi Kiflen, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 14, 2023
"I don't need any more unknowns hanging over my head": Views of patients with cancer on variants of uncertain significance and low/moderate risk results from genomic sequencingSalma Shickh, Chloe Mighton, Marc Clausen, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 25, 2022
"Doctors shouldn't have to cheat the system": Clinicians' real-world experiences of the utility of genomic sequencingSalma Shickh, Chloe Mighton, Marc Clausen, et al.
European Journal of Human Genetics : EJHG|March 29, 2021
Widening the lens of actionability: A qualitative study of primary care providers' views and experiences of managing secondary genomic findingsAgnes Sebastian, June C Carroll, Meredith Vanstone, et al.
Human Genetics|September 6, 2020
Beyond medically actionable results: an analytical pipeline for decreasing the burden of returning all clinically significant secondary findingsEmma Reble, Mariana Gutierrez Salazar, Kathleen-Rose Zakoor, et al.
European Journal of Medical Genetics|November 12, 2021
Challenges and practical solutions for managing secondary genomic findings in primary careAgnes Sebastian, June C Carroll, Meredith Vanstone, et al.
European Journal of Human Genetics : EJHG|April 29, 2018
The Genomics ADvISER: development and usability testing of a decision aid for the selection of incidental sequencing resultsYvonne Bombard, Marc Clausen, Chloe Mighton, et al.
Pageof 7

Showing results (21-30 of 68) with videos related to

Sort By:
Pageof 7
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 3, 2019
Correction: Variant classification changes over time in BRCA1 and BRCA2Chloe Mighton, George S Charames, Marina Wang, et al.
HGG Advances|May 1, 2025
Pathogenic germline variants in small cell lung cancer: A systematic review and meta-analysisSami Ul Haq, Aleem Aamir, Chloe Mighton, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 12, 2019
Variant classification changes over time in BRCA1 and BRCA2Chloe Mighton, George S Charames, Marina Wang, et al.
CMAJ Open|November 25, 2020
Use of real-world evidence in cancer drug funding decisions in Canada: a qualitative study of stakeholders' perspectivesMarc Clausen, Chloe Mighton, Ruhi Kiflen, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 14, 2023
"I don't need any more unknowns hanging over my head": Views of patients with cancer on variants of uncertain significance and low/moderate risk results from genomic sequencingSalma Shickh, Chloe Mighton, Marc Clausen, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 25, 2022
"Doctors shouldn't have to cheat the system": Clinicians' real-world experiences of the utility of genomic sequencingSalma Shickh, Chloe Mighton, Marc Clausen, et al.
European Journal of Human Genetics : EJHG|March 29, 2021
Widening the lens of actionability: A qualitative study of primary care providers' views and experiences of managing secondary genomic findingsAgnes Sebastian, June C Carroll, Meredith Vanstone, et al.
Human Genetics|September 6, 2020
Beyond medically actionable results: an analytical pipeline for decreasing the burden of returning all clinically significant secondary findingsEmma Reble, Mariana Gutierrez Salazar, Kathleen-Rose Zakoor, et al.
European Journal of Medical Genetics|November 12, 2021
Challenges and practical solutions for managing secondary genomic findings in primary careAgnes Sebastian, June C Carroll, Meredith Vanstone, et al.
European Journal of Human Genetics : EJHG|April 29, 2018
The Genomics ADvISER: development and usability testing of a decision aid for the selection of incidental sequencing resultsYvonne Bombard, Marc Clausen, Chloe Mighton, et al.
Pageof 7